Last reviewed · How we verify

NCT05476575

The Effect of Perioperative Hydrogen Inhalation on Post-operative Pain and Inflammation Cytokines

Completed NA Last updated 17 February 2026
What this trial tests

NA trial testing hydrogen inhalation, 4% concentration, given via nasal cannula in Pain, Acute in 37 participants. Completed in 28 February 2025.

Timeline
28 October 2021
Primary endpoint
30 December 2024
28 February 2025

Quick facts

Lead sponsorFu Jen Catholic University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment37
Start date28 October 2021
Primary completion30 December 2024
Estimated completion28 February 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Fu Jen Catholic University Hospital

Who can join

Adults 20 to 75, any sex, with Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To understand the impact of perioperative hydrogen inhalation on post-operative pain control and serum inflammation markers

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Acute

Currently open trials in the same condition.

Other Fu Jen Catholic University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05476575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing